Stay tuned and follow the latest
developments and news in Molecular Oncology.
What are the suspicious symptoms that will lead to the possible diagnosis of childhood cancer? – Fever without a clear source of infection. – Mass (tumor) in any part of […]
Read More
According to a new Italian scientific study published in the Journal of Thoracic Oncology of the International Association for the Study of Lung Cancer, patients with lung cancer who quit […]
Read More
The TV show “Igia Pano Apo Ola” was in Genekor’s Laboratory to meet the iGEM Patras 2021, the student team who won the Bronze medal in the 2021 GiANT JAMBOREE […]
Read More
The use of multi-gene panels for germline testing in breast cancer enables the estimation of cancer risk and guides risk-reducing management options. The aim of this study was to present […]
Read More
The poster of the study conducted by Genekor’s Scientific Team “Different Copy Number Variations (CNVs) account for 10.4% of pathogenic variants in 1418 patients referred for hereditary breast cancer testing” […]
Read More
Daphne Karavokyri shares her new documentary on Hereditary Cancer and the HerediGene genetic test she performed at Genekor. Daphne Karavokyri shares her new documentary on Hereditary Cancer and the HerediGene […]
Read More
NGS PLATFORM – ITS CONTRIBUTION TO CLINICAL PRACTICE In recent years, Next Generation Sequencing (NGS) technologyhas been actively introduced into clinical practice,playing an essential role in understandingthe genetics of many […]
Read More
Genekor’s scientific team, from the very first days of its establishment, has focused on the use and development of new technologies and the quality of services provided. In this way […]
Read More
RxPONDER Study Results Demonstrate that the Oncotype DX® Test Can Now Spare Chemotherapy Use in the Majority of Womenwith Node-positive Early-stage Breast Cancer • First results from the independent SWOG […]
Read More